Quasi‑psychiatric Agitation

What is Quasi‑psychiatric agitation?

Quasi‑psychiatric agitation is a state of heightened motor activity, restlessness, and emotional turbulence that resembles psychiatric agitation (as seen in conditions such as acute mania or psychosis) but is triggered by medical, metabolic, or neurologic disturbances rather than a primary mental‑health disorder. Patients may feel “on edge,” display rapid speech, have a low threshold for frustration, and be difficult to settle. The term is used primarily by clinicians to signal that the agitation is secondary—often reversible—once the underlying physical cause is treated.¹

Because the presentation bridges neurology, internal medicine, and psychiatry, a systematic evaluation is essential. Untreated agitation can lead to injury, escalation of medical complications, and, in severe cases, transition to delirium or violent behavior. Early recognition and targeted therapy improve outcomes and may prevent unnecessary psychiatric admission.

Common Causes

The following medical conditions are among the most frequent triggers of quasi‑psychiatric agitation:

• Infections – urinary tract infection, pneumonia, sepsis, or meningitis, especially in older adults.
• Metabolic disturbances – hypoglycemia, hyperglycemia, hypernatremia, hyponatremia, hepatic encephalopathy, renal failure (uremia).
• Medication side‑effects or withdrawal – steroids, anticholinergics, benzodiazepine or alcohol withdrawal, opioid toxicity.
• Neurologic events – stroke, transient ischemic attack, traumatic brain injury, seizures, or status epilepticus.
• Endocrine disorders – thyroid storm (hyperthyroidism), adrenal crisis (addisonian crisis), pheochromocytoma.
• Substance intoxication – stimulants (cocaine, methamphetamine), hallucinogens, synthetic cannabinoids.
• Cardiopulmonary distress – hypoxia from COPD exacerbation, pulmonary embolism, heart failure.
• Autoimmune / inflammatory conditions – systemic lupus erythematosus, vasculitis, paraneoplastic syndromes.
• Neoplastic processes – brain tumors, metastatic disease causing raised intracranial pressure.
• Post‑operative or ICU delirium – often multifactorial (pain, sleep deprivation, sensory overload).

Associated Symptoms

Quasi‑psychiatric agitation rarely occurs in isolation. Common accompanying signs include:

• Rapid, pressured speech or nonsensical rambling
• Physical restlessness – pacing, hand‑wringing, inability to sit still
• Emotional lability – sudden crying, irritability, irritant outbursts
• Sleep disturbances – insomnia or fragmented sleep
• Autonomic changes – sweating, tachycardia, hypertension, flushing
• Altered cognition – confusion, disorientation, difficulty concentrating
• Visual or auditory hallucinations (often with metabolic or drug‑induced causes)
• Gastro‑intestinal symptoms – nausea, vomiting, abdominal pain (e.g., with hyperammonemia)

When to See a Doctor

While mild restlessness can be a normal response to stress, you should seek professional care promptly if any of the following occur:

• Agitation develops suddenly or worsens rapidly (within hours).
• There is confusion, disorientation, or difficulty following simple commands.
• Physical safety is at risk – the person is aggressive, trying to harm themselves or others.
• Fever, rapid heart rate, or high blood pressure accompany the agitation.
• Recent changes in medication, substance use, or withdrawal symptoms.
• History of dementia, stroke, or severe medical illness that could predispose to delirium.
• Persistent agitation lasting more than 24‑48 hours despite calming measures.

When in doubt, call your primary‑care provider or go to an urgent‑care clinic. If safety is threatened, seek emergency care.

Diagnosis

Evaluation follows a structured, step‑wise approach:

1. Clinical Interview & History

• Onset, duration, and pattern of agitation.
• Recent infections, surgeries, medication changes, substance use, or trauma.
• Past medical history (e.g., liver disease, renal failure, psychiatric illness).
• Family or caregiver observations of baseline mental status.

2. Physical Examination

• Vital signs (temperature, pulse, blood pressure, respiratory rate, oxygen saturation).
• Neurologic assessment – level of consciousness, pupillary response, focal deficits.
• Signs of infection (e.g., lung crackles, urinary tenderness) or endocrine crises (e.g., tremor, skin changes).

3. Laboratory Tests

• Basic metabolic panel (electrolytes, glucose, renal function, calcium).
• Liver panel, ammonia level if hepatic disease suspected.
• Complete blood count (infection, anemia).
• Thyroid function tests, cortisol levels for endocrine causes.
• Urine drug screen or toxicology panel if substance use is possible.

4. Imaging & Other Diagnostics

• Head CT or MRI if stroke, bleed, or mass is suspected.
• Chest X‑ray for pneumonia or pulmonary edema.
• ECG – to detect arrhythmias or myocarditis in stimulant intoxication.
• EEG if seizure activity or non‑convulsive status epilepticus is a concern.

5. Screening for Delirium

Tools such as the Confusion Assessment Method (CAM) help differentiate delirium‑related agitation from primary psychiatric disorders.²

Treatment Options

Effective management targets the underlying cause while providing symptomatic relief and ensuring safety.

Medical Interventions

• Treat the precipitating illness – antibiotics for infection, insulin for hyperglycemia, dialysis for uremia, or thyroxine for thyroid storm.
• Reversal of toxic/metabolic states – glucose for hypoglycemia, flumazenil for benzodiazepine overdose, naloxone for opioid toxicity.
• Medications for agitation (used judiciously):
  • Low‑dose haloperidol or atypical antipsychotics (e.g., olanzapine) – effective for severe agitation; monitor QT interval.
  • Short‑acting benzodiazepines (e.g., lorazepam) – preferred for withdrawal‑related agitation or when catatonia is present; avoid in respiratory compromise.
  • Alpha‑2 agonists (e.g., clonidine, dexmedetomidine) – useful in stimulant intoxication or autonomic instability.
• Supportive care – oxygen supplementation, fluid and electrolyte correction, pain control, and sleep promotion.

Non‑pharmacologic Strategies

• Environmental modification – reduce noise, keep lighting soft, maintain a calm tone, and limit the number of staff entering the room.
• Reorientation techniques – clocks, calendars, clear introductions (“My name is …”), and brief reminders of location and time.
• Physical safety measures – low beds, padded rails, removal of hazardous objects, and bedside sitter if needed.
• Relaxation techniques – deep‑breathing exercises, guided imagery, or soft music when the patient is able to participate.

Discharge & Follow‑up

After stabilization, arrange follow‑up with the primary‑care provider, a neurologist, or a psychiatrist, depending on the identified cause. Medication reconciliation and education about warning signs are essential to prevent recurrence.

Prevention Tips

While some triggers (e.g., acute stroke) are unpredictable, many strategies reduce the risk of quasi‑psychiatric agitation:

• Adhere strictly to medication schedules; use pill organizers or reminder apps.
• Stay hydrated and maintain balanced electrolytes, especially in the elderly.
• Monitor blood glucose, thyroid, and renal function regularly if you have chronic disease.
• Avoid abrupt cessation of CNS‑active drugs; taper under medical supervision.
• Limit alcohol and recreational stimulant use.
• Vaccinate against common infections (influenza, pneumococcus, COVID‑19) to reduce delirium‑causing sepsis.
• Promote good sleep hygiene – regular bedtime, minimize daytime naps, reduce caffeine after midday.
• For caregivers of dementia patients, maintain a predictable routine and use visual cues.
• During hospital stays, ask staff to orient you regularly and request a calm environment.

Emergency Warning Signs